معرفی
Idris Raji is an Assistant Professor in the Department of Chemistry and Biochemistry at the University of Oklahoma. His research focuses on nanoparticle-based drug delivery systems for genetic medicines and vaccines, small molecule immune modulators, and epigenetic regulation of immune responses. He holds a B.S. from AAUA (2007), M.S. from the University of Ibadan (2011), Ph.D. from Georgia Tech (2016), and postdoctoral training at MIT (2019-2022), Baylor College of Medicine (2017-2019), and Harvard Medical School (2022-2023).
Research Interests:
- Development of lipid nanoparticles (LNPs) for tissue-specific delivery of genetic medicines
- Design of small molecule STING agonists for immunotherapy
- Molecular probes to study epigenetic regulation of innate immunity
- Machine learning-guided optimization of LNP formulations
His work bridges chemistry and medicine, addressing challenges in targeting therapies to diseased tissues while minimizing systemic toxicity. Recent efforts include AI-driven discovery of ionizable lipids and combinatorial formulation strategies for mRNA vaccines.
Grants & Advising: While specific grants are not listed, his research is funded through competitive academic grants. No advisees are publicly listed at this time.
Labs/Teams: The Raji Laboratory at OU focuses on translational nanomedicine and immunomodulatory small molecules.
